Latest Healthtech Startup Funding Rounds
Companies building technology for healthcare delivery, diagnosis, clinical workflows and patient access.
- Rounds
- 744 Jan 1 – Oct 24, 2026
- Disclosed funding
- $25.3B 606 disclosed amounts
- Median round
- $16M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| C CurifyLabsCompany profile CurifyLabs develops software and GMP-manufactured excipients for preparing personalized medicines. CurifyLabs develops software and GMP-manufactured excipients for preparing personalized medicines. | $14M | Series A | Healthtech | Finland | Investors | |
| S Develops AI infrastructure for data privacy and security | $18M | Undisclosed | Healthtech, Cybersecurity | Spain | Investors | |
| CT Develops treatments for serious respiratory diseases | $180M | Growth | Healthtech, Biotech | United States | Investors | |
| B Develops wearable EEG technology for cognitive performance improvement | €650K | Pre-SeedPre-seed | Healthtech | Sweden | Investors | |
| MM Develops medical devices for women's pelvic health | $5M | Series B | Healthtech | United States | Investors | |
| Q Builds fully autonomous robotic pharmacy for prescription fulfillment | $12.6M | Seed | Healthtech | United States | Investors | |
| XB Xellar BiosystemsCompany profile Develops 3D human tissue models for drug discovery and testing using Organ-on-a-Chip technology Develops 3D human tissue models for drug discovery and testing using Organ-on-a-Chip technology | $50M | Series A | Healthtech, Biotech | United States | Investors Undisclosed | |
| A AlanCompany profile Alan combines health insurance, preventive services and access to care in a digital platform for employers and members. Alan combines health insurance, preventive services and access to care in a digital platform for employers and members. | €480M | Series GSeries C+ | Healthtech, Fintech | France | Investors | |
| LL Leyden LaboratoriesCompany profile Develops antibody-based nasal sprays intended to prevent influenza and other respiratory-virus infections. Develops antibody-based nasal sprays intended to prevent influenza and other respiratory-virus infections. | €40M | Series B | Healthtech, Biotech | Netherlands | Investors | |
| T TissiumCompany profile Develops biomorphic programmable polymers that repair nerves and tissue without stitches Develops biomorphic programmable polymers that repair nerves and tissue without stitches | €30M | Series D+Series C+ | Healthtech | France | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1General Catalyst
Baba, Disha (formerly Curelink), Thatch
23rounds2led - 2Y Combinator (YC)
Vitalize, Angle Health, Metriport
21rounds0led - 3Alumni Ventures
MintNeuro, Evvy, Hopscotch Primary Care
13rounds0led - 4Andreessen Horowitz (a16z)
Sharp Performance, General Medicine, Devoted Health
12rounds2led - 5Khosla Ventures
Even Healthcare, Abby Care, Rightway
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.